Mobia Medical, Inc. (MOBI) – What Are Analysts Thinking About This Stock?

Mobia Medical, Inc. (NASDAQ:MOBI) has been assigned an average recommendation of “Moderate Buy” from the seven analysts that are presently covering the stock, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and five have assigned a buy rating to the company. The average 12-month price target among brokerages that have covered the stock in the last year is $20.75.

A number of brokerages have recently commented on MOBI. Wall Street Zen raised shares of Mobia Medical from a “sell” rating to a “hold” rating in a report on Sunday, June 14th. JPMorgan Chase & Co. boosted their price target on Mobia Medical from $15.00 to $17.00 and gave the company an “overweight” rating in a report on Wednesday, August 12th. Weiss Ratings initiated coverage on shares of Mobia Medical in a research note on Wednesday, August 12th. They set a “sell (e-)” rating on the stock. Finally, BTIG Research reiterated a “buy” rating and issued a $19.00 price objective on shares of Mobia Medical in a report on Wednesday, August 12th.

Mobia Medical Stock Up 0.8%

MOBI stock opened at $8.63 on Monday. The firm’s 50-day moving average is $10.65. The company has a quick ratio of 12.80, a current ratio of 13.28 and a debt-to-equity ratio of 0.04. Mobia Medical has a twelve month low of $8.29 and a twelve month high of $15.29. The stock has a market cap of $287.29 million and a price-to-earnings ratio of -0.43.

Mobia Medical (NASDAQ:MOBI) last posted its earnings results on Tuesday, August 11th. The company reported ($1.10) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.83) by ($0.27). The company had revenue of $13.51 million for the quarter. The business’s quarterly revenue was up 102.4% compared to the same quarter last year. On average, equities research analysts anticipate that Mobia Medical will post -2.63 EPS for the current fiscal year.

Insider Transactions at Mobia Medical

In related news, Director Casey Tansey bought 35,572 shares of the business’s stock in a transaction on Thursday, August 13th. The stock was acquired at an average price of $11.51 per share, with a total value of $409,433.72. Following the transaction, the director owned 268,904 shares in the company, valued at approximately $3,095,085.04. This trade represents a 15.25% increase in their position. The purchase was disclosed in a filing with the SEC, which is accessible through this link. Over the last quarter, insiders purchased 87,000 shares of company stock valued at $1,016,367.

Hedge Funds Weigh In On Mobia Medical

Several large investors have recently made changes to their positions in MOBI. State Street Corp purchased a new position in Mobia Medical during the second quarter valued at $735,000. Citadel Advisors LLC purchased a new stake in Mobia Medical in the 2nd quarter worth about $670,000. Finally, Readystate Asset Management LP bought a new stake in shares of Mobia Medical during the 2nd quarter worth approximately $134,000.

Mobia Medical Company Profile

Mobia Medical Inc is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. Mobia Medical Inc is based in AUSTIN, Texas.